Literature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactions JD Duke, X Han, Z Wang, A Subhadarshini, SD Karnik, X Li, SD Hall, ... PLoS computational biology 8 (8), 2012 | 130 | 2012 |
Pharmacoepidemiologic Methods for Studying the Health Effects of Drug–Drug Interactions S Hennessy, CE Leonard, JJ Gagne, JH Flory, X Han, CM Brensinger, ... Clinical Pharmacology & Therapeutics 99 (1), 92-100, 2016 | 88 | 2016 |
Comparative risk of serious hypoglycemia with oral antidiabetic monotherapy: A retrospective cohort study CE Leonard, X Han, CM Brensinger, WB Bilker, S Cardillo, JH Flory, ... Pharmacoepidemiology and drug safety 27 (1), 9-18, 2018 | 68 | 2018 |
An integrated pharmacokinetics ontology and corpus for text mining HY Wu, S Karnik, A Subhadarshini, Z Wang, S Philips, X Han, C Chiang, ... BMC bioinformatics 14, 1-15, 2013 | 57 | 2013 |
Pro-and Antiarrhythmic Actions of Sulfonylureas: Mechanistic and Clinical Evidence CE Leonard, S Hennessy, X Han, DS Siscovick, JH Flory, R Deo Trends in Endocrinology & Metabolism 28 (8), 561-586, 2017 | 48 | 2017 |
Successful Comparison of US Food and Drug Administration Sentinel Analysis Tools to Traditional Approaches in Quantifying a Known Drug‐Adverse Event Association JJ Gagne, X Han, S Hennessy, CE Leonard, EA Chrischilles, ... Clinical Pharmacology & Therapeutics 100 (5), 558-564, 2016 | 37 | 2016 |
Severe hypoglycemia in users of sulfonylurea antidiabetic agents and antihyperlipidemics CE Leonard, WB Bilker, CM Brensinger, X Han, JH Flory, DA Flockhart, ... Clinical Pharmacology & Therapeutics 99 (5), 538-547, 2016 | 36 | 2016 |
Gastrointestinal bleeding and intracranial hemorrhage in concomitant users of warfarin and antihyperlipidemics CE Leonard, CM Brensinger, WB Bilker, SE Kimmel, X Han, YH Nam, ... International Journal of Cardiology 228, 761-770, 2017 | 34 | 2017 |
Pharmacoepidemiologic and in vitro evaluation of potential drug–drug interactions of sulfonylureas with fibrates and statins H Schelleman, X Han, CM Brensinger, SK Quinney, WB Bilker, ... British journal of clinical pharmacology 78 (3), 639-648, 2014 | 29 | 2014 |
Serious hypoglycemia and use of warfarin in combination with sulfonylureas or metformin YH Nam, CM Brensinger, WB Bilker, CE Leonard, X Han, S Hennessy Clinical Pharmacology & Therapeutics 105 (1), 210-218, 2019 | 23 | 2019 |
Biomedical Informatics Approaches to Identifying Drug–Drug Interactions: Application to Insulin Secretagogues X Han, CW Chiang, CE Leonard, WB Bilker, CM Brensinger, L Li, ... Epidemiology 28 (3), 459-468, 2017 | 22 | 2017 |
Identification and Mechanistic Investigation of Drug–Drug Interactions Associated With Myopathy: A Translational Approach X Han, SK Quinney, Z Wang, P Zhang, J Duke, Z Desta, JS Elmendorf, ... Clinical Pharmacology & Therapeutics 98 (3), 321-327, 2015 | 22 | 2015 |
Inhibition of Cytochrome P450 Enzymes by the E-and Z-Isomers of Norendoxifen J Liu, PJ Flockhart, D Lu, W Lv, WJ Lu, X Han, M Cushman, DA Flockhart Drug Metabolism and Disposition 41 (9), 1715-1720, 2013 | 21 | 2013 |
Comparative risk of severe hypoglycemia among concomitant users of thiazolidinedione antidiabetic agents and antihyperlipidemics CE Leonard, X Han, WB Bilker, JH Flory, CM Brensinger, DA Flockhart, ... Diabetes Research and Clinical Practice 115, 60-67, 2016 | 7 | 2016 |
Sulfonylureas and metformin were not associated with an increased rate of serious bleeding in warfarin users: a self‐controlled case series study YH Nam, X Han, CM Brensinger, WB Bilker, CE Leonard, S Hennessy Clinical Pharmacology & Therapeutics 108 (5), 1010-1017, 2020 | 5 | 2020 |
xIP-seq platform: an integrative framework for high-throughput sequencing data analysis X Wang, M Teng, G Wang, Y Zhao, X Han, W Feng, L Li, J Sanford, Y Liu 2009 Ohio Collaborative Conference on Bioinformatics, 26-31, 2009 | 3 | 2009 |
Identification and mechanistic investigation of clinically important myopathic drug-drug interactions X Han Indiana University, 2014 | 1 | 2014 |
558 Relationship Between Patient Characteristics and Number of Procedures as Well as Length of Stay for Patients Surviving Severe Burn Injuries: Analysis of the American Burn … S Kowal, E Kruger, SP Bilir, JH Holmes IV, KN Foster Journal of Burn Care & Research 41 (Supplement_1), S119-S120, 2020 | | 2020 |
Serious bleeding and use of warfarin in combination with sulfonylureas or metformin YH Nam, CM Brensinger, WB Bilker, CE Leonard, X Han, S Hennessy PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 27, 33-34, 2018 | | 2018 |
Relationship Between Patient Characteristics and Length of Stay for Severe Burn Patients: Analysis of the American Burn Association National Burn Repository E Kruger, SP Bilir, S Kowal, E Han Value in Health 21, S109-S110, 2018 | | 2018 |